← All trials
NCT04453111
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 2, 2020
- Primary completion
- Aug 31, 2021
- Completion date
- Oct 31, 2021
- First posted
- Jul 1, 2020
- Last posted
- Jul 7, 2020
- Enrollment
- 45
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Institute of Cell TherapyLead sponsor
- Institute of Cell TherapyStudy director
- Kyiv City Clinical Hospital № 6Collaborator
- The Institute of Traumatology and Orthopedics of NAMS of UkraineCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.